Coformulated N-Octanoyl-glucosylceramide Improves Cellular Delivery and Cytotoxicity of Liposomal Doxorubicin
Robert Jan Veldman(The Netherlands Cancer Institute), Wim J. van Blitterswijk(The Netherlands Cancer Institute), Marcel Verheij(Radboud University Nijmegen), Shuraila F. Zerp(The Netherlands Cancer Institute), Stefan R. Vink(The Netherlands Cancer Institute), Gert Storm(Yong In University), Albert J. van Hell, Gerben A. Koning(Università Cattolica del Sacro Cuore)
Cited by 33
Related Papers
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
|Frontiers in Pharmacology|2018|937
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
|The Lancet Oncology|2018|582
Sheddable Coatings for Long-Circulating Nanoparticles
|Pharmaceutical Research|2007|549